Stock Yearly Return 2015
Start date: 12/31/2014
End date: 12/31/2015
Start price/share: $0.61
End price/share: $0.51
Dividends collected/share: $0.00
Total return: -16.39%
Average Annual Total Return: -16.39%
Starting investment: $10,000.00
Ending investment: $8,361.00
Years: 1.00


IMV average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare IMV average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into IMV


Also see:
IMV stock yearly return 2016
IMV stock yearly return 2017
IMV stock yearly return 2018
IMV stock yearly return 2019
IMV stock yearly return 2020
IMV YTD return
IMV average annual return 10 years
IMV, through its subsidiary, ImmunoVaccine Technologies Inc., is a clinical stage biopharmaceutical company that develops products based on its proprietary vaccine enhancement platform with a primary focus on T cell activating therapies for cancers. Co. also capitalizes on licensing opportunities of its platform for other applications including infectious diseases. Co.'s proprietary DepoVax™ adjuvanting/delivery platform is believed to produce an immune response that has a specific and sustained immune effect, and enables Co. to pursue vaccine candidates in cancer, infectious diseases and potentially other vaccine applications. The IMV stock yearly return is shown above.

The yearly return on the IMV stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2015 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the IMV annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for IMV:
IMV SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
IMV (IMV) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

INCY Average Annual Return
INFI Average Annual Return
INGN Average Annual Return
INO Average Annual Return
INSM Average Annual Return
INSY Average Annual Return
INVA Average Annual Return
IONS Average Annual Return
IOVA Average Annual Return
IPCI Average Annual Return
More Healthcare companies »

 

IMV Stock Yearly Return 2015 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.